T-cell count
1 paper
- Human trial1
Latest
1 in 12 monthsThe Journals of Gerontology, Series A
Stability and Predictors of Phenotypic Age Acceleration among Virally Suppressed Asians with HIV over Five Years
Cohort study of 728 peoplePopulations
The Lancet Oncology
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
Non-randomised trial in 55 peopleSenolytics